05/24/2024
2:13 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
3:18 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:19 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
2:20 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
11:04 AM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:11 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/16/2024
3:12 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:13 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:14 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
11:59 AM | AS YOU SOW (Filed by)
Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024
12:10 PM | Chevedden John (Filed by)
Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024
11:20 AM | Eli Lilly and Company (Subject)
Trinity Health Corp (Filed by)
| Form PX14A6G | |
03/11/2024
3:24 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:26 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:18 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
10:44 AM | Eli Lilly and Company (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
2:05 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:43 PM | Dozier Eric (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:44 PM | Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:34 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:36 PM | Eli Lilly and Company (Issuer)
Skovronsky Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:25 PM | Eli Lilly and Company (Issuer)
Jonsson Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
10:56 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
8:26 AM | Eli Lilly and Company (Subject)
PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
| Form SC 13G/A | |
02/08/2024
2:34 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:08 PM | Eli Lilly and Company (Subject)
| Form FWP | |
02/07/2024
7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/06/2024
6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:32 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Eli Lilly and Company (Subject)
| Form SC 13G/A | |
01/17/2024
3:15 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:17 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:19 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
2:22 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:05 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
1:15 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
2:11 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The 7th Trillion Dollar Company? (Ad) There are six American companies worth more than $1 trillion currently.
But is there going to be a 7th trillion dollar company soon? This company just signed a MASSIVE deal with Apple. |
12/22/2023
5:40 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/18/2023
5:59 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/04/2023
3:17 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:04 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/21/2023
3:27 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:29 PM | Eli Lilly and Company (Issuer)
Runge Marschall S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:15 PM | Baicker Katherine (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:18 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:20 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:22 PM | Eli Lilly and Company (Issuer)
JACKSON JAMERE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:24 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:53 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/15/2023
5:51 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/08/2023
4:06 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/06/2023
5:09 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
3:25 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
10:21 AM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:02 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
3:15 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
10/17/2023
3:19 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:21 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:22 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:24 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:15 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:18 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
5:52 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T | |
10/12/2023
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
1:06 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023
3:25 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:27 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:28 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:29 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:22 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:24 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:14 PM | Eli Lilly and Company (Issuer)
Weems Alonzo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:26 PM | Eli Lilly and Company (Subject)
Weems Alonzo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
1:37 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023
12:44 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023
3:33 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:34 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:24 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:26 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:28 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:29 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:31 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
12:31 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
2:50 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:34 AM | Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
| Form SC TO-T/A | |
08/09/2023
1:32 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
08/09/2023
8:14 AM | DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
| Form SC TO-T/A | |
08/08/2023
12:23 PM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:01 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
3:46 PM | Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
| Form SC TO-T/A | |
07/25/2023
6:04 AM | DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
| Form SC TO-T/A | |
07/24/2023
2:55 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
1:55 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
3:33 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
3:36 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
